This report was first published by Endpoints News. To see the original version, click here
Aditum Bio, the biotech company creation firm from former Novartis leaders Joe Jimenez and Mark Fishman, has returned to China for another deal.
This time, Aditum is forming a new company called Clavis Bio to develop medicines as part of a five-year collaboration with Fosun Pharma.
您已閱讀13%（371字），剩余87%（2579字）包含更多重要信息，訂閱以繼續(xù)探索完整內(nèi)容，并享受更多專屬服務(wù)。